EGFR and renal carcinoma: Song et al. (2014[76]) reported that kaempferol effectively inhibited EGFR/p38 signaling activation, reduced cyclin B1 expression and increased p21 expression along with PARP cleavage and induced apoptosis in human renal carcinoma (786-O and 769-P) cells.